Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia

Onkologie

Volumn 32, Issue 8-9, 2009, Pages 513-515

  Szotkowski, Tomas ^a   Jarosova, Marie ^a   Faber, Edgar ^a   Hubacek, Jaromir ^a   Hlusi, Antonin ^a   Papajik, Tomas ^a   Pikalova, Zuzana ^a   Kucerova, Ladislava ^a   Holzerova, Milena ^a   Budikova, Miroslava ^a   Buriankova, Eva ^a   Plachy, Radek ^a   Potomkova, Jarmila ^b   Klusova, Natalie ^a   Szotkowska, Romana ^a   Indrak, Karel ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Acute promyelocytic leukemia; Adverse effect; Secondary malignancy; T lymphoblastic lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD5 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUORODEOXYGLUCOSE F 18; RETINOIC ACID; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLAST CELL; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHROMOSOME 12Q; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XX; LYMPHOMA; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; PRECURSOR T LYMPHOBLASTIC LYMPHOMA; PROMYELOCYTIC LEUKEMIA; TREATMENT OUTCOME; TUMOR REGRESSION;

ADULT; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 70149120608     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226584     Document Type: Article

References (10)

1. Panizo C, Patiiio A, Lecumberri R, Calasanz MJ, Odero MD, Bendandi M, Rocha E: Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases. Cancer Genet Cytogenet2003;143:178-181.
2. Huang FS, Zwerdling T, Stern LE, Ballard ET, Warner BW: Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J Pediatr Hematol Oncol 2001;23:609-611.
3. Athanasiadou A, Saloum R, Zorbas I, Tsompana-kou A, Batsis I, Fassas A, Anagnostopoulos A: Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines. Leuk Lymphoma 2002;43:2409-2411.
4. Bee PC, Gan GG, Sangkar JV, Teh A, Goh KY: A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia. Int J Hematol 2004;79:358-360.
5. Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lo Coco F, Mandelli F: Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood 2002;99:822-824.
6. Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T, Diaz-Mediavilla J, Fioritoni G, Gonzalez JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzales M, Rodeghiero F, Co-lomer D, Petti MC, Ribera JM, Mandelli F: Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHE-MA and GIMEMA cooperative groups. Blood 2000;96:1247-1253.
7. Ades L, Sanz MA, Chevret S, Montesinos P, Chev-allier P, Raffoux E, Vellenga E, Guerci A, Pigneux A, Huguet F, Rayon C, Stoppa AM, de la Serna J, Cahn J-Y, Meyer-Monard S, Pabst T, Thomas X, de Botton S, Parody R, Bergua J, Larny T, Vekhoff A, Negri S, Ifrah N, Dombret H, Ferrant A, Bron D, Degos L, Fenaux P: Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood 2008;lll:1078-1084.
8. Sawada H, Morimoto H, Wake A, Yamasaki Y, Izumi Y: Therapy-related acute myeloid leukemia with t(10;ll)(q23;pl5) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21). Int J Hematol 1999:69:270-271.
9. Au WY, Lam CC, Ma ES, Man C, Wan T, Kwong YL: Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features. Hum Pathol 2001:32:126-129.
10. Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M, Nedoszytko B, Kytola S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Sak-sela K, Peterson P, Visakorpi T, Ranki A: Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res 2005;65:8101-8110.